# Supporting Information A review of fungal protoilludane sesquiterpenoid natural products

CorpusID: 229685147
 
tags: #Medicine, #Chemistry, #Biology

URL: [https://www.semanticscholar.org/paper/fe9354366cde08efb85c023b6cf3168c3db57912](https://www.semanticscholar.org/paper/fe9354366cde08efb85c023b6cf3168c3db57912)
 
| Is Survey?        | Result          |
| ----------------- | --------------- |
| By Classifier     | False |
| By Annotator      | (Not Annotated) |

---

Supporting Information A review of fungal protoilludane sesquiterpenoid natural products


Melissa M Cadelis m.cadelis@auckland.ac.nz 
School of Chemical Sciences
University of Auckland
23 Symonds Street1010AucklandNew Zealand

Bioluminescent Superbugs Lab
School of Medical Sciences
University of Auckland
85 Park Road1023Grafton, AucklandNew Zealand

Brent R Copp b.copp@auckland.ac.nz 
School of Chemical Sciences
University of Auckland
23 Symonds Street1010AucklandNew Zealand

Siouxsie Wiles s.wiles@auckland.ac.nz 
Bioluminescent Superbugs Lab
School of Medical Sciences
University of Auckland
85 Park Road1023Grafton, AucklandNew Zealand

Supporting Information A review of fungal protoilludane sesquiterpenoid natural products



## 3-epi-Illudol (3)

Clitocybe candicans, 1989 [7] Antimicrobial activity against E. coli ATCC25922 MIC 32 µg/mL [8]. Inactive against P. multocida ATCC15743 and M. haemolytica ATCC14003 [9].

1989-Relative by NOESY. Absolute established by partial resolution method of Horeau on an acetonide derivative and ECD on 1-O-pivaloyl-3,6-dinitrobenzoyl derivative [7].

1997 -racemic [10] 1-O-Acetyl-3-epi-illudol (4) Clitocybe candicans, 1989 [7] 1989-Relative established by biogenetic consideration with 3-epi-illudol [7].

Illudiolone (5) Omphalotus illudens, 2002 [11] 2002-X-ray [11].

5-O-Acetyl-7,14dihydroxyprotoilludanol (6) Conocybe siliginea, 2015 [12] No cytotoxicity against human cancer cell lines SK-BR-3, SMMC-7721, HL-60, PANC-1 and A-549 (IC50 >40 µM) [12].

2015-Relative by ROESY [12].
Δ 6 -Protoilludene (7)
Fomitopsis insularis, 1977 [13] 1985-Relative established by synthesis [14].


# -racemic [14]

Δ 7 -Protoilludene-6-ol (8) Fomitopsis insularis, 1977 [13] Δ 7 -Protoilludene (9) Dictyostelium discoideum, 2016 [15] 2016-Relative established by NOESY. Absolute established by conversion of synthetic (R)-1-2 H)FPP to Δ 7protoilludene [15].

1979 -racemic [16] Mucoroidiol (10) Dictyostelium mucoroides, 2020 [17] No cytotoxicity against HeLa cells (IC50 >40 µM). No antibacterial activity against S. aureus or E. coli [17].


## 2020-

Relative established by NOESY. Absolute by biogenetic consideration with Δ 7 -protoilludene [17].

Sulcatine A (11) Laurilia sulcate, 1987 [18] No antifungal activity against C. cucumerinum (200 µg) and C. albicans (200 µg). Antimicrobial activity (MIC 32 µg/mL) against E. coli ATCC25922. Inactive against P. multocida ATCC15743 and M. haemolytica ATCC14003 [9].

1987-Relative by NOESY. Absolute established by ECD on dibenzoate derivative [18].

Sulcatine B (12) Laurilia sulcate, 1992 [19] Antifungal activity against C. cucumerinum (50 µg) and C. albicans (50 µg) [19].

Antimicrobial activity (MIC 32 µg/mL) against E.

coli ATCC25922 and M. haemolytica ATCC14003. Inactive against P. multocida ATCC15743 [9]. 1992-Relative by NOESY of sulcatine B and its hydroxy diacetate derivative. Absolute established by biogenetic consideration with sulcatine A [19].

Armillol (13) Laurilia sulcate, 1992 [19] and 3-epi-illudol [19].

Tsugicoline A (15) Laurilia tsugicola, 1995 [20] Allelopathic activity against L. sativum. Inactive against B. subtilis, B. cereus, S. lutea, C. cladosporioides and S. cerevisiae at 100 µg [20]. Antimicrobial activity (MIC 32 µg/mL) against E.

coli ATCC25922 and M. haemolytica ATCC14003 but inactive against P. multocida ATCC15743 [9]. 1995-Relative established by NOESY. Absolute established by partial resolution method of Horeau [20].

Tsugicoline B (16) Laurilia tsugicola, 1995 [20] 1995-Relative established by biogenetic consideration with A [20].

Tsugicoline C (17) Laurilia tsugicola, 1995 [20] Antimicrobial activity (MIC 32 µg/mL) against E.

coli ATCC25922 and M. haemolytica ATCC14003 but inactive against P. multocida ATCC15743 [9].


## 1995-

Relative established by NOESY [20].

Tsugicoline D (18) Laurilia tsugicola, 1995 [20] 1995-Relative established by NOESY [20].


## Tsugicoline E (19)

Laurilia tsugicola, 1999 [21] Antimicrobial activity against E. coli ATCC25922 MIC 32 µg/mL but inactive against P. multocida ATCC15743 and M. haemolytica ATCC14003 [9]. Inactive against B. subtilis, B. cereus and S. cerevisiae at 100 µg [21].


## 1999-

Absolute established by Xray [21].

Tsugicoline M (20)

Clavicorona pyxidata YB2005, 2009 [22] No antimicrobial activity against E. coli, B. subtilis, S. aureus and C. albicans at 50 µg/mL. No cytotoxicity against HeLa cells at 20 µg/mL [22].


## 2009-Relative by NOESY [22]

Pyxidatol A (21)

Clavicorona pyxidata, 2008 [23] 2008-Relative by ROESY. Absolute established by biogenetic consideration with tsugicoline E [23].


## Pyxidatol B (22)

Clavicorona pyxidata, 2008 [23] 2008-Relative by ROESY. Absolute established by biogenetic consideration with tsugicoline E [23].

Plorantinone A (23) Russula delica, 1997 [24] 1997 -Relative by NOESY. Absolute established by biogenetic consideration to plorantinone B [24].


## Plorantinone B (24)

Russula delica, 1997 [24] 1997 -Relative by NOESY. Absolute ECD and conformational analysis and molecular mechanics calculations [24].

Plorantinone C (25) Russula delica, 1997 [24] 1997 -Relative by NOESY. Absolute established by biogenetic consideration with plorantinone B [24].

Plorantinone D (26) Russula delica, 1998 [25] epi-Plorantinone B (27) Russula delica, 1998 [25] Stearoyl plorantinone B (28) Russula delica, 1997 [24] 1997 -Relative by NOESY. Absolute established by biogenetic consideration with plorantinone B [24].

Stearoyl delicone (29) Russula delica, 1997 [26] 1997 -Relative NOESY. Absolute established by biogenetic consideration with plorantinone B [24,26].


## Russujaponol A (30)

Russula japonica, 2006 [27] Suppressed invasion of human fibrosarcoma (HT1080) cells into Matrigel, 63% inhibition at 3.73 µM. No cytotoxicity against 39 human cancer cell lines [27].


## 2006-Relative by NOESY.

Absolute by X-ray of benzoate derivative [27].


## Russujaponol B (31)

Russula japonica, 2006 [27] No cytotoxicity against 39 human cancer cell lines [27].


## 2006-Relative by

NOESY and biogenetic consideration with russujaponol A [27].


## Russujaponol C (32)

Russula japonica, 2006 [27] 2006-Relative by NOESY and biogenetic consideration with russujaponol A [27].


## Russujaponol D (33)

Russula japonica, 2006 [27] No cytotoxicity against 39 human cancer cell lines [27].


## 2006-Relative by

NOESY and biogenetic consideration with russujaponol A [27].


## Atlanticone A (34)

Lactarius atlanticus, 2002 [28] Inactive against S. aureus and E. coli [28].

2002 -Relative by NOESY. Absolute by PM3 calculation and ECD comparison with plorantinone B [28].


## Atlanticone B (35)

Lactarius atlanticus, 2002 [28] Inactive against S. aureus and E. coli [28].

2002-Relative by NOESY [28].


## Atlanticone C (36)

Lactarius atlanticus, 2002 [28] 2002-Relative by NOESY [28].


# -Racemic

[29] 2020 -Enantioselectiv e synthesis [30] Atlanticone D (37) Lactarius atlanticus, 2002 [28] 2002-Relative by NOESY [28].

Repraesentin A (38)


## Lactarius repraesentaneus,

2003 [31] Promotion of radicle elongation of lettuce seedlings [31].


## 2003-Relative by

NOESY. Absolute by biogenetic consideration with Δ 6 -protoilludene [31].


## Pasteurestin A (39)

Agrocybe aegerita, 2002 [32] Antimicrobial activity against P. multocida (MIC 8 µg/mL) and M. haemolytica [9].


## 2008-

Absolute established by stereoselective synthesis [33,34].


## 2008stereoselective

synthesis [33,34].


## Pasteurestin B (40)

Agrocybe aegerita, 2002 [32] Antimicrobial activity against P. multocida (MIC 1 µg/mL) and M. haemolytica [9].


## 2008-

Absolute established by stereoselective synthesis [33,34].


## 2008stereoselective

synthesis [33,34].


## Pasteurestin C (41)

Agrocybe aegerita, 2019 [35] 2019-Relative by ROESY. Absolute by biogenetic consideration with Pasteurestins A and B [35].


## Epicoterpene A (42)

Armillaria sp. and Epicoccum sp., 2020 [36] No cytotoxicity against HL-60, A-549, SMMC-7721, MCF-7, SW480 (IC50 >40 µM). No acetylcholinesterase inhibitory activity at 50 µM [36]. 2020-Relative by ROESY. Absolute by ECD [36].

Epicoterpene B (43) Armillaria sp. and Epicoccum sp., 2020 [36] No cytotoxicity against HL-60, A-549, SMMC-7721, MCF-7, SW480 (IC50 >40 µM). No acetylcholinesterase inhibitory activity at 50 µM [36].


## 2020-Relative by

ROESY. Absolute by ECD [36].


## Epicoterpene C (44)

Armillaria sp. and Epicoccum sp., 2020 [36] No cytotoxicity against HL-60, A-549, SMMC-7721, MCF-7, SW480 (IC50 >40 µM). No acetylcholinesterase inhibitory activity at 50 µM [36].


## 2020-Relative by

ROESY. Absolute by ECD [36].


## Epicoterpene E (45)

Armillaria sp. and Epicoccum sp., 2020 [36] No cytotoxicity against HL-60, A-549, SMMC-7721, MCF-7, SW480 (IC50 >40 µM). No acetylcholinesterase inhibitory activity at 50 µM [36].  [38].


## 2020-


## 1996-Relative by NOESY. Absolute

by biogenetic consideration [38].


## Radudiol (48)

Radulomyces confluens, 1988 [39] Cytotoxicity against HeLa S3 (IC50 >400 µM), HL-60 (IC50 >400 µM) and L-1210 (IC50 188 µM) [39].

1988-Relative by NOESY [39].


## 2016-


## Stereoselective

synthesis of non-natural enantiomer [40].


## Radulone A (49)

Radulomyces confluens, 1988 [39] Potent inhibitor of human and bovine platelet aggregation [39]. No haemolytic effects on bovine erythrocytes at concentration of 400 µM [39]. 1988-Relative by NOESY [39].


## Radulone B (50)

Radulomyces confluens, 1988 [39] Cytotoxicity against HeLa S3 (IC50 >400 µM), HL-60 (IC50 431 µM) and L-1210 (IC50 431 µM) [39]. Granulobasidium vellereum, 2013 [43] No antifungal activity against P. canescens, F. oxysporum, H. occidentale, C. sporulosum, C. puteana and B. adusta [43]. [43].


## 1988-


## 2013-Absolute by ROESY and ECD


## 2a-Hydroxycoprinolone (54)

Granulobasidium vellereum, 2014 [44] No antifungal activity against P. canescens, F. oxysporum and H. occidentale at 100 µg/mL [44].


## 2014-Relative by ROESY. Absolute by ECD. [44]

3-Hydroxycoprinolone (55)

Granulobasidium vellereum, 2014 [44] No antifungal activity against P. canescens, F. oxysporum and H. occidentale at 100 µg/mL [44].


## 2014-Relative by

ROESY. Absolute by ECD [44].


## Coprinolone diol B (56)

Granulobasidium vellereum, 2014 [44] No antifungal activity against P. canescens, F. oxysporum and H. occidentale at 100 µg/mL [44].


## 2014-Relative by ROESY. Absolute by biogenetic consideration with

coprinolone diol [44].
8-Deoxy-4a- hydroxytsugicoline A(57)
Granulobasidium vellereum, 2013 [43] No antifungal activity against P. canescens, F. oxysporum, H. occidentale, C. sporulosum, C. puteana and B. adusta [43].


## 2013-Relative by ROESY. Absolute by biogenetic consideration with

2hydroxycoprinolon e [43].
8-Deoxy-4a- hydroxytsugicoline B(58)
Granulobasidium vellereum, 2014 [44] No antifungal activity against P. canescens, F. oxysporum and H. occidentale at 100 µg/mL [44].


## 2014-Relative by ROESY. Absolute by biogenetic consideration with

8-deoxy-4ahydroxytsugicoline [44].


## 8-Deoxydihydrotsugicolin e (59)

Granulobasidium vellereum, 2013 [43] No antifungal activity against P. canescens, F. oxysporum, H. occidentale, C. sporulosum, C. puteana and B. adusta [43].

2013-Relative by ROESY. Absolute by biogenetic consideration with 2hydroxycoprinolon e and ECD [43].


## 2016-Stereoselective

synthesis of non-natural enantiomer [40].

Granulodiene A (60)

Granulobasidium vellereum, 2014 [44] No antifungal activity against P. canescens, F. oxysporum and H. occidentale at 100 µg/mL [44].


## 2014-Relative by

ROESY. Absolute by ECD [44].


## Granulodiene B (61)

Granulobasidium vellereum, 2014 [44] No antifungal activity against P. canescens, F. oxysporum and H. occidentale at 100 µg/mL [44].


## 2014-Relative by

ROESY. Absolute by ECD [44].


## Granulone A (62)

Granulobasidium vellereum, 2014 [44] No antifungal activity against P. canescens, F. oxysporum and H. occidentale at 100 µg/mL [44].


## 2014-Relative by

ROESY. Absolute by biogenetic consideration with radulone B [44].


## Granulone B (63)

Granulobasidium vellereum, 2014 [44] No antifungal activity against P. canescens, F. oxysporum and H. occidentale at 100 µg/mL [44].


## 2014-Relative by ROESY.

Absolute by biogenetic consideration with granulone A [44].

Demethylgranulone (64) Granulobasidium vellereum, 2014 [44] No antifungal activity against P. canescens, F. oxysporum and H. occidentale at 100 µg/mL [44]. Antibacterial activity against B. subtilis ATCC6633 (5.6γ) and S. aureus ATCC53156 (5.6γ) [48]. Antibacterial activity against B. subtilis (0.5 µg) and E. coli (1.0 µg) [49]. Antifungal activity against C. cucumerinum (inactive) and C. albicans (1.0 µg) [49].


## 2014-


## 1982-Absolute by

ECD and X-ray of hydroxyaldehyde derivative [48,50].

Judeol (70) Armillaria mellea, 1985 [51] Antibacterial activity against B subtilis ATCC6633 (5.6γ) and S. aureus ATCC53156 (8.7γ) [51]. No activity against P. aeruginosa or E. coli [51].

Armillyl everninate (71) Armillaria mellea, 1986 [52] No antibacterial activity (Gram-positive) [52].

Arnamiol (72) Armillaria mellea, 1986 [52] No antibacterial activity (Gram-positive) [52].

Armillaribin ( 


## 1982-

Absolute by X-ray [60].


# -Racemic [46]

Melleolide B (79) Armillaria mellea, 1986 [62] Antibacterial activity against B. cereus (ATCC10702), B. subtilis (ATCC6633) and E. coli (ATCC10536) [62]. Cytotoxicity against HL-60 (IC50 >40 µM), SMMC-7721 (IC50 >40 µM), A-549 (IC50 >40 µM), MCF-7 (IC50 >40 µM) and SW480 (IC50 >40 µM) [63].

1986-Relative by NOESY [62].


## Melleolide C (80)

Armillaria mellea, 1986 [62] Antibacterial activity against B. cereus (ATCC10702), B. subtilis (ATCC6633) and E. coli (ATCC10536) [62]. Not cytotoxic against HCT-116, MCF7, Jurkat and CCRF-CEM at IC50 100 µM [56].

1986-Relative by NOESY [62].


## Melleolide D (81)

Armillaria mellea, 1986 [62] Antibacterial activity against B. cereus (ATCC10702), B. subtilis (ATCC6633) and E. coli (ATCC10536) [62]. Cytotoxicity against HCT-116 (IC50 >100 µM), MCF7 (IC50 >100 µM), Jurkat (IC50 >100 µM), HeLa (IC50 >100 µM), K-562 (IC50 >100 µM) and CCRF-CEM (IC50 61.66 µM) [56].

1986-Relative by NOESY and biogenetic consideration with melleolide C [62].


## Melleolide E (82)

Armillaria mellea, 1988 [64] 1988-Relative by NOESY [64]. 1988-Relative by NOESY [64].


# -Racemic [46]

Melleolide G (84) Armillaria mellea, 1988 [64] 1988-Relative by NOESY [64].


## Melleolide H (85)

Armillaria mellea, 1988 [64] 1988-Relative by NOESY [64]. 


## 13-Hydroxymelleolide K/ Melleolide T (93)

Armillaria mellea, 2011 [67] Cytotoxicity against MCF7 (IC50 >100 µM), H460 (IC50 >100 µM), HT-29 (IC50 32.1±3.6 µM) and CEM (IC50 5.5±0.6 µM) [55].


## 2016-

Relative by biogenetic consideration with melleolide D. Absolute established by ECD [61].


## 4-O-Methylmelleolide (94)

Armillaria mellea, 1985 [51] Antibacterial activity against B. subtilis ATCC6633 (5.6γ) and S. aureus ATCC53156 (8.7γ).

No activity against P. aeruginosa or E. coli [51].


## 1985-Absolute by

X-ray [51].


## Dihydromelleolide (95)

Armillaria mellea, 1988 [68] 13-Hydroxydihydromelleol ide (96) Armillaria mellea, 1990 [69] Cytotoxicity against MCF7 (IC50 >100 µM), Jurkat (IC50 >100 µM), HeLa (IC50 >100 µM) and K-562 (IC50 >100 µM). Antibacterial activity against B. subtilis (0.5 µg) and E. coli (1.0 µg) [49]. Antifungal activity against C. cucumerinum (1.0 µg) and C. albicans (1.0 µg) [49].


## 1990-


## 2000-Relative by

NOESY [49].

6'-Chloro-13-hydroxydihydromelleolide (102)

Armillaria mellea, 2011 [59] Cytotoxicity against MCF7 (IC50 >100 µM), Jurkat (IC50 46.6±3.1 µM), HeLa (IC50 >100 µM) and K-562 (IC50 >100 µM) [59]. 50 µg/mL), F. pinicola (MIC 50 µg/mL), P. oxalicum (MIC >100 µg/mL), A. flavus (MIC >100 µg/mL), T. harzianum (MIC >100 µg/mL), M. racemosus (MIC >100 µg/mL) and S. scabies (MIC >100 µg/mL) [58].


## Melledonal B (104)

Armillaria mellea, 1988 [71] Cytotoxicity (IC50 >100 µM) against MCF7, H460, HT-29 and CEM [55]. Antibacterial activity (100 µg) against B. cereus (ATCC10702) and B. subtilis (ATCC6633) [71].


## 1988-Absolute by

biogenetic consideration with C [71].


## Melledonal C (105)

Armillaria mellea, 1988 [71] Cytotoxicity against HCT-116 (IC50 >100 µM), MCF7 (IC50 >100 µM), Jurkat (IC50 58.75 µM) and CCRF-CEM (IC50 14.75 µM) [56]. Cytotoxicity against MCF7 (IC50 >100 µM), H460 (IC50 >100 µM), HT-29 (IC50 85.6±9.1 µM) and CEM (IC50 49.6±5.2 µM) [55]. Antibacterial activity against B. subtilis (0.5 µg) and E. coli (1.0 µg) [49]. Antifungal activity against C. cucumerinum (inactive)


## 1988-Absolute by

X-ray [71].

and Candida albicans (3.0 µg) [49]. Antimicrobial activity (MIC 32 µg/mL) against E.

coli ATCC25922 [71]. Inactive against P. multocida ATCC15743 and M. haemolytica ATCC14003 [9].


## 15-Hydroxy-5'-Omethylmelledonal (106)

Armillaria mellea, 1987 [72] 1987-Relative by NOESY on dibenzoate derivative [72].


## 5'-O-methylmelledonal (107)

Armillaria mellea, 1987 [72] 1987-Relative by biogenetic consideration with melleodonal [72].


## Melledonal D (108)

Clitocybe elegans, 1988 [64] 1988-Relative by NOESY [64].


## Melledonal E (109)

Clitocybe elegans, 1988 [64] 1988-Relative by NOESY [64].


## Melledonol (110)

Armillaria mellea, 1985 [70] Not cytotoxic against HCT-116, MCF7, Jurkat and CCRF-CEM at IC50 100 µM [56].


## Armillarin (111)

Armillaria mellea, 1984 [73] No antibiotic activity against H. annosum, G. abietinum, E. coli, M. luteus, B. subtilis, C. albicans and S. aureus [74]. Cytotoxicity against MCF7 (IC50 11.6±0.5 µM), HeLa (IC50 16.7±2.1 µM), K-562 (IC50 9.9±0.6 µM) [59]. Cytotoxicity against HUVEC (GI50 9.9±0.8 µM), K-562 (GI50 9.9±0.6 µM), MCF-7 (GI50 11.6±0.5 µM) and HeLa (CC50 16.7±2.1 µM) [57].


## 1984-

Absolute by X-ray [73]. 1991-Relative by NOESY [79].

Armillatin (120) Armillaria mellea, 1991 [79] 1991-Relative by NOESY [79].

Armillaric acid (121) Armillaria mellea, 1989 [80] Antimicrobial activity against at 250 µg/mL S. aureus (19.8mm), M. lutaus (8.8 mm) and C. albicans (10.1 mm) [81].

1990-Relative by NOESY [81].

10α-Hydroxyarmillarin (122)

Armillaria mellea, 1990 [82] 1990-Relative by biogenetic consideration with melleolide B [82].


## 4-O-Methylarmillaridin (123)

Armillaria mellea, 1990 [82] Cytotoxicity against MCF7 (IC50 6.7±1.1 µM), Jurkat (IC50 4.1±0.8 µM), HeLa (IC50 18.8±2.9 µM) and K-562 (IC50 20.6±2.2 µM) [59].


## 1990-Relative by biogenetic consideration with

4-Omethylmelleolide [82].


## 5'-Methoxy-armillasin (124)

Armillaria mellea, 2016 [61] 2016-Relative by NOESY [61].


## 5-Hydroxyl-armillarivin (125)

Armillaria mellea, 2016 [61] Cytotoxicity against HepG2 (IC50 18.03±6.03 µM) and L02 (IC50 22.70±1.42 µM) [61].

2016-Relative by NOESY [61].


## Armellide A (126)

Armillaria novaezelandiae, 1988 [65] 1998-Relative by NOESY [65].


## Armellide B (127)

Armillaria novaezelandiae, 1988 [65] Cytotoxicity against MCF7 (IC50 >100 µM), Jurkat (IC50 >100 µM), HeLa (IC50 >100 µM) and K-562 (IC50 >100 µM) [59].

1998-Relative by NOESY [65].


## 13-Deoxyarmellide A (128)

Armillaria mellea, 2014 [57] Cytotoxicity against HUVEC (GI50 >115 µM), K-562 (GI50 >115 µM), MCF-7 (GI50 >115 µM) and HeLa (CC50 >115 µM) [57]. Cytospora sp., 2017 [89] No cytotoxicity against HeLa cells (IC50 >100 µM) [89].


## 2014-


## 2017-Absolute by biogenetic consideration with

6hydroxypunctapor onin A [89].

Punctaporonin Q (163) Cytospora sp., 2017 [89] No cytotoxicity against HeLa cells (IC50 >100 µM) [89]. Inhibitor of BACE1 (target for Alzheimer disease) (~39% inhibition at 40 µM). No hepatoxicity to L-02 liver cells at 40 µM [92].


## 2017-


## 2018-

Absolute established by Xray [92].


## Marine


## Paesslerin A (174)

Alcyonium paessleri, 2001 [93] Moderate cytotoxicity in preliminary studies [93].


## 2001-Relative by

NOESY [93].


## 2019-Total synthesis and

structure correction [94] Paesslerin B (175) Alcyonium paessleri, 2001 [93] Moderate cytotoxicity in preliminary studies [93].


## 2001-Relative by

NOESY [93].


## Plants


## Pteridanoside (176)

Pteridium aquilinum var. caudatum, 1999 [95] Toxicity against brine shrimp Artemia salina (LC50 = 250 and 62.5 µg/mL, 24h and 48h) [95].


## 1999-

Relative established by NOESY. Absolute by biogenetic consideration with pteridanone [95].


against C. insiduodum (MIC 20 µM), M. luteus (MIC 20 µM), S. bikiniensis (MIC 40 µM), N. coryli (MIC 20 µM), S. cerevisiae (MIC 41 µM), M. miehei (MIC 41 µM) and U. nuda (MIC 20 µM) [39].


No hepatoxicity to L-02 liver cells at 40 µM[92]. No hepatoxicity to L-02 liver cells at 40 µM[92]. No hepatoxicity to L-02 liver cells at 40 µM[92]. No hepatoxicity to L-02 liver cells at 40 µM[92].2018-Relative by NOESY. Absolute established by ECD[92]. No hepatoxicity to L-02 liver cells at 40 µM[92]. No hepatoxicity to L-02 liver cells at 40 µM[92].Absolute by 
biogenetic 
consideration with 
6-
hydroxypunctapor 
onin A [89]. 

Punctaporonin R (164) 
Cytospora sp., 
2017 [89] 

Moderate cytotoxicity 
against HeLa cells (IC50 
10.4 µM) [89]. 

2017-Absolute by 
biogenetic 
consideration with 
6-
hydroxypunctapor 
onin E [89]. 

Punctaporonin S (165) 
Cytospora sp., 
2017 [89] 

Weak cytotoxicity against 
HeLa cells (IC50 47.4 µM) 
[89]. 

2017-Absolute by 
biogenetic 
consideration with 
6-
hydroxypunctapor 
onin E [89]. 

Phomophyllin B (166) 

Phomopsis sp. 
TJ507A, 2018 
[92] 

Inhibitor of BACE1 (target 
for Alzheimer disease) 
(~35% inhibition at 40 
µM). 
2018-Relative by 
NOESY. Absolute 
established by X-
ray [92]. 

Phomophyllin C (167) 

Phomopsis sp. 
TJ507A, 2018 
[92] 

Inhibitor of BACE1 (target 
for Alzheimer disease) 
(~20% inhibition at 40 
µM). 
2018-Relative by 
NOESY. Absolute 
established by ECD 
[92]. 

Phomophyllin D (168) 

Phomopsis sp. 
TJ507A, 2018 
[92] 

Inhibitor of BACE1 (target 
for Alzheimer disease) 
(~40% inhibition at 40 
µM). 
2018-Relative by 
NOESY. Absolute 
established by ECD 
[92]. 

Phomophyllin E (169) 

Phomopsis sp. 
TJ507A, 2018 
[92] 

Inhibitor of BACE1 (target 
for Alzheimer disease) 
(~37% inhibition at 40 
µM). 
Phomophyllin F (170) 

Phomopsis sp. 
TJ507A, 2018 
[92] 

Inhibitor of BACE1 (target 
for Alzheimer disease) 
(~38% inhibition at 40 
µM). 
2018-Relative by 
NOESY. Absolute 
established by 
modified Mosher's 
method (MTPA) 
[92]. 

Phomophyllin G (171) 

Phomopsis sp. 
TJ507A, 2018 
[92] 

Inhibitor of BACE1 (target 
for Alzheimer disease) 
(~21% inhibition at 40 
µM). 
2018-Relative by 
NOESY. Absolute 
established by 
modified Mosher's 
method (MTPA) 
[92]. 

Phomophyllin H (172) 

Phomopsis sp. 
TJ507A, 2018 
[92] 

2018-Relative by 
NOESY. Absolute 
established by ECD 
[92]. 

Phomophyllin I (173) 

Phomopsis sp. 
TJ507A, 2018 
[92] 


Armilliphatic A (140)Armillaria sp. and Epicoccum sp., 2020[36]Moderate cytotoxicity against HL-60 (IC50 15.8±0.32[36]. 2020-Relative by ROESY. Absolute by ECD[36].13,14-Dihydroxy-A52a (141)Armillaria mellea, 2011[59]Cytotoxicity against MCF7 (IC50 >100 µM), Jurkat (IC50 >100 µM), HeLa (IC50 >100 µM) and K-562 (IC50 >100 µM)[59].Armillane / Armillarizin (142)Armillaria mellea, 1990[82]1990-Relative established by NOESY[82].5'-Ascomycota Punctaporonin A (148)Poronia punctata, 1984[85]1984-X-ray[85]1986-Absolute established by synthesis[86]1986enantiospecific[86]Punctaporonin D (149)Poronia punctata, 1986[87]Inhibits a mycelial form of C. albicans at 1ppm[87].1986-X-ray[87]1986-Absolute established by synthesis[86]1986enantiospecific[86]Punctaporonin E (150) Poronia punctata, 1986[87]Inhibits T. vaginalis at 100 ppm in vitro[87].1986-X-ray of punctatin E acetonide[87]Punctaporonin F (151)Poronia punctata, 1986[87]6-Hydroxypunctaporonin A (152)Pestalotiopsis disseminate, 2006[88]No activity against B. subtilis (ATCC6051), S. aureus (ATCC29213), E.coli (ATCC25922) and C. albicans (ATCC14053)[88].No cytotoxicity against HeLa cells (IC50 >100 µM)[89].[88].2006-No cytotoxicity against HeLa cells (IC50 >100 µM)[89].[90].2006-2014-Relative byNOESY[90].Punctaporonin N (156) Pestalotiopsis sp., 2016[91]No antifungal activity against A. flavus and F. verticillioides and no antimicrobial activity against S. aureus, B. subtilis, E. coli and C. albicans on disks at 100 µg[91].2016-Absolute by oxidation of 6hydroxypunctaporonin A and biogenetic consideration[91].Punctaporonin O (157)Pestalotiopsis sp., 2016[91]No antifungal activity against A. flavus and F. verticillioides and no antimicrobial activity against S. aureus, B. subtilis, E. coli and C. albicans on disks at 100 µg[91]. Pteridanone(177)Pteridium aquilinum var. caudatum, 1999[95]No toxicity against brine shrimp Artemia salina[95]. Improve the cell viability of human umbilical vein endothelial cells injured by ox-LDL[98].2016-1999-2016-Relative byNOESY. Absolute by ECD[98].
. M Anchel, A Hervey, W J Robbins, Pnas, 36Anchel, M.; Hervey, A.; Robbins, W.J. PNAS 1950, 36, 300-305.

. T C Mcmorris, M S R Nair, M Anchel, J. Am. Chem. Soc. 89McMorris, T.C.; Nair, M.S.R.; Anchel, M. J. Am. Chem. Soc. 1967, 89, 4562-4563.

. T C Mcmorris, M S R Nair, P Singh, M Anchel, Phytochemistry. 101611McMorris, T.C.; Nair, M.S.R.; Singh, P.; Anchel, M. Phytochemistry 1971, 10, 1611.

. T Matsumoto, K Miyano, S Kagawa, S Yi, J Ogawa, A Ichihara, Tet. Lett. 38Matsumoto, T.; Miyano, K.; Kagawa, S.; Yi, S.; Ogawa, J.; Ichihara, A. Tet. Lett. 1971, 38, 3521-3524.

. M S R Nair, M Anchel, Tet. Lett. 14Nair, M.S.R.; Anchel, M. Tet. Lett. 1975, 14, 1267-1268.

. S Suzuki, T Murayama, Y Shiono, Z. Naturforsch. 61Suzuki, S.; Murayama, T.; Shiono, Y. Z. Naturforsch. 2006, 61b, 1295-1298.

. A Arnone, R Cardillo, V D Modugno, G J Nasini, Chem. Soc. Perkin Trans. 1. Arnone, A.; Cardillo, R.; Modugno, V.D.; Nasini, G. J. Chem. Soc. Perkin Trans. 1 1989, 1995-2000.

. S Suzuki, T Murayama, Y Shiono, Phytochemistry. 66Suzuki, S.; Murayama, T.; Shiono, Y. Phytochemistry 2005, 66, 2329-2333.

. G Assante, S Dallavalle, P A Martino, J Antibiot. 66Assante, G.; Dallavalle, S.; Martino, P.A. J Antibiot 2013, 66, 43-45.

. M R Elliott, A.-L Dhimane, M Malacria, J. Am. Chem. Soc. 119Elliott, M.R.; Dhimane, A.-L.; Malacria, M. J. Am. Chem. Soc. 1997, 119, 3427-3428.

. T C Mcmorris, A Kashinatham, R Lira, H Rundgren, P K Gantzel, M J Kelner, R Dawe, Phytochemistry. 61McMorris, T.C.; Kashinatham, A.; Lira, R.; Rundgren, H.; Gantzel, P.K.; Kelner, M.J.; Dawe, R. Phytochemistry 2002, 61, 395-398.

. X.-Y Yang, Z.-H Li, Z.-J Dong, T Feng, J.-K Liu, J. Asian Nat. Prod. Res. 17Yang, X.-Y.; Li, Z.-H.; Dong, Z.-J.; Feng, T.; Liu, J.-K. J. Asian Nat. Prod. Res. 2015, 17, 1-6.

. S Nozoe, H Kobayashi, S Urano, J Furukawa, Tet. Lett. Nozoe, S.; Kobayashi, H.; Urano, S.; Furukawa, J. Tet. Lett. 1977, 1381-1384.

. J Furukawa, N Morisaki, H Kobayashi, S Iwasaki, S Nozoe, S Okuda, Chem. Pharm. Bull. 33Furukawa, J.; Morisaki, N.; Kobayashi, H.; Iwasaki, S.; Nozoe, S.; Okuda, S. Chem. Pharm. Bull. 1985, 33, 440-443.

. P Rabe, J Rinkel, B Nubbemeyer, T G Köllner, F Chen, J S Dickschat, Angew. Chem. Int. Ed. 55Rabe, P.; Rinkel, J.; Nubbemeyer, B.; Köllner, T.G.; Chen, F.; Dickschat, J.S. Angew. Chem. Int. Ed. 2016, 55, 15420-15423.

. H Takeshita, H Iwabuchi, I Kouno, M Iino, D Nomura, Chem. Lett. 8Takeshita, H.; Iwabuchi, H.; Kouno, I.; Iino, M.; Nomura, D. Chem. Lett. 1979, 8, 649-652.

. H Sasaki, Y Kubohara, H Ishigaki, K Takahashi, H Eguchi, A Sugawara, Y Oshima, H Kikuchi, Sasaki, H.; Kubohara, Y.; Ishigaki, H.; Takahashi, K.; Eguchi, H.; Sugawara, A.; Oshima, Y.; Kikuchi, H. Molecules 2020, 25, 2895.

. A Arnone, G Nasini, G Assante, H J Roeijmans, G W Van Euk, Phytochemistry. 26Arnone, A.; Nasini, G.; Assante, G.; Roeijmans, H.J.; Van Euk, G.W. Phytochemistry 1987, 26, 1739-1742.

. A Arnone, G Nasini, G Assante, G W Eijk, Phytochemistry. 31Arnone, A.; Nasini, G.; Assante, G.; Eijk, G.W.V. Phytochemistry 1992, 31, 2047-2050.

. A Arnone, U Brambilla, G Nasini, O V De Pava, Tetrahedron. 51Arnone, A.; Brambilla, U.; Nasini, G.; de Pava, O.V. Tetrahedron 1995, 51, 13357-13364.

. A Arnone, C De Gregorio, S V Meille, G Nasini, G Sidoti, J. Nat. Prod. 62Arnone, A.; De Gregorio, C.; Meille, S.V.; Nasini, G.; Sidoti, G. J. Nat. Prod. 1999, 62, 51-53.

. Y Zheng, Y Shen, Org. Lett. 11Zheng, Y.; Shen, Y. Org. Lett. 2009, 11, 109-112.

. Y.-B Zheng, C.-H Lu, Z.-H Zheng, X.-J Lin, W.-J Su, Y.-M Shen, Helv. Chim. Acta. 91Zheng, Y.-B.; Lu, C.-H.; Zheng, Z.-H.; Lin, X.-J.; Su, W.-J.; Shen, Y.-M. Helv. Chim. Acta. 2008, 91, 2174-2180.

. M Clericuzio, J Fu, F Pan, Z Pang, O Sterner, Tetrahedron. 53Clericuzio, M.; Fu, J.; Pan, F.; Pang, Z.; Sterner, O. Tetrahedron 1997, 53, 9735-9740.

. M Clericuzio, F Han, F Pan, Z Pang, O Sterner, Acta Chem. Scand. 52Clericuzio, M.; Han, F.; Pan, F.; Pang, Z.; Sterner, O. Acta Chem. Scand. 1998, 52, 1333-1337.

. M Clericuzio, F Pan, F Han, Z Pang, O Sterner, Tet. Lett. 38Clericuzio, M.; Pan, F.; Han, F.; Pang, Z.; Sterner, O. Tet. Lett. 1997, 38, 8237-8240.

. K Yoshikawa, A Kaneko, Y Matsumoto, H Hama, S Arihara, J. Nat. Prod. 69Yoshikawa, K.; Kaneko, A.; Matsumoto, Y.; Hama, H.; Arihara, S. J. Nat. Prod. 2006, 69, 1267-1270.

. M Clericuzio, M Mella, L Toma, P V Finzi, G Vidari, Eur. J. Org. Chem. 6Clericuzio, M.; Mella, M.; Toma, L.; Finzi, P.V.; Vidari, G. Eur. J. Org. Chem. 2002, 6, 988-994.

. A Zech, C Jandl, T Bach, Angew. Chem. Int. Ed. 58Zech, A.; Jandl, C.; Bach, T. Angew. Chem. Int. Ed. 2019, 58, 14629-14632.

. J Proessdorf, A Zech, C Jandl, T Bach, 31Proessdorf, J.; Zech, A.; Jandl, C.; Bach, T. Synlett 2020, 31, 1598-1602.

. M Hirota, Y Shimizu, T Kamo, H Makabe, H Shibata, Biosci. Biotechnol. Biochem. 67Hirota, M.; Shimizu, Y.; Kamo, T.; Makabe, H.; Shibata, H. Biosci. Biotechnol. Biochem. 2003, 67, 1597-1600.

Antibiotic pasteurestin A and B and their manufacture with Agrocybe cylindracea. T Takeuchi, H Iinuma, I Momose, S Matsui, Jpn. Kokai Tokkyo Koho. JPTakeuchi, T.; Iinuma, H.; Momose, I.; Matsui, S. Antibiotic pasteurestin A and B and their manufacture with Agrocybe cylindracea. 2002, Jpn. Kokai Tokkyo Koho, JP 2002212137.

. M Kögl, L Brecker, R Warrass, J Mulzer, Angew. Chem. Int. Ed. 46Kögl, M.; Brecker, L.; Warrass, R.; Mulzer, J. Angew. Chem. Int. Ed. 2007, 46, 9320-9322

. M Kögl, L Brecker, R Warrass, J Mulzer, Eur. J. Org. Chem. Kögl, M.; Brecker, L.; Warrass, R.; Mulzer, J. Eur. J. Org. Chem. 2008, 2714-2730.

. F Surup, F Hennicke, N Sella, M Stroot, S Bernecker, S Pfütze, M Stadler, M Rühl, Beilstein J. Org. Chem. 15Surup, F.; Hennicke, F.; Sella, N.; Stroot, M.; Bernecker, S.; Pfütze, S.; Stadler, M.; Rühl, M. Beilstein J. Org. Chem. 2019, 15, 1000-1007.

. H.-T Li, L.-H Tang, T Liu, R.-N Yang, Y.-B Yang, H Zhou, Z.-T Ding, Bioorg. Chem. 103503Li, H.-T.; Tang, L.-H.; Liu, T.; Yang, R.-N.; Yang, Y.-B.; Zhou, H.; Ding, Z.-T. Bioorg. Chem. 2020, 95, 103503.

. A Stärk, T Anke, U Mocek, W Steglich, A Kirfel, G Will, Z. Naturforsch. C. 43Stärk, A.; Anke, T.; Mocek, U.; Steglich, W.; Kirfel, A.; Will, G. Z. Naturforsch. C 1988, 43, 177-183.

. A Wunder, T Anke, D Klostermeyer, W Steglich, Z. Naturforsch. C. 51Wunder, A.; Anke, T.; Klostermeyer, D.; Steglich, W. Z. Naturforsch. C 1996, 51, 493-499.

. K Fabian, K Lorenzen, T Anke, M Johansson, O Sterner, Z. Naturforsch. C. 53Fabian, K.; Lorenzen, K.; Anke, T.; Johansson, M.; Sterner, O. Z. Naturforsch. C 1998, 53, 939-945.

. E L Chang, B Bolte, P Lan, A C Willis, M G Banwell, J. Org. Chem. 81Chang, E.L.; Bolte, B.; Lan, P.; Willis, A.C.; Banwell, M.G. J. Org. Chem. 2016, 81, 2078-2086.

. A N Starratt, J B Stothers, E W B Ward, J. Chem. Soc., Chem. Commun. Starratt, A.N.; Stothers, J.B.; Ward, E.W.B. J. Chem. Soc., Chem. Commun. 1988, 590-591.

. A N Starratt, E W B Ward, J B Stothers, Can. J. Chem. 67Starratt, A.N.; Ward, E.W.B.; Stothers, J.B. Can. J. Chem. 1989, 67, 417-427.

. C L Nord, A Menkis, R Vasaitis, A Broberg, Phytochemistry. 90Nord, C.L.; Menkis, A.; Vasaitis, R.; Broberg, A. Phytochemistry 2013, 90, 128-134.

. C L Nord, A Menkis, C Lendel, R Vasaitis, Broberg, Phytochemistry. 102Nord, C.L.; Menkis, A.; Lendel, C.; Vasaitis, R.; Broberg, Phytochemistry 2014, 102, 197-204.

. Y Shiono, T Seto, M Kamata, C Takita, S Suzuki, T Murayama, M Z Ikeda, Naturforsch, 59Shiono, Y.; Seto, T.; Kamata, M.; Takita, C.; Suzuki, S.; Murayama, T.; Ikeda, M. Z. Naturforsch. 2004, 59b, 925-929.

. K Shimoda, Y Yamaoka, D Yoo, K Yamada, H Takikawa, K Takasu, J. Org. Chem. 84Shimoda, K.; Yamaoka, Y.; Yoo, D.; Yamada, K.; Takikawa, H.; Takasu, K. J. Org. Chem. 2019, 84, 11014-11024.

. Y Shiono, S Suzuki, T Murayama, M Ikeda, Y Abe, T Sassa, Z. Naturforsch. B. 60Shiono, Y.; Suzuki, S.; Murayama, T.; Ikeda, M.; Abe, Y.; Sassa, T. Z. Naturforsch. B 2005, 60, 449-452.

. D Donnelly, S Sanada, J O&apos;reilly, J Polonsky, T Prangé, C Pascard, J. Chem. Soc., Chem. Commun. Donnelly, D.; Sanada, S.; O'Reilly, J.; Polonsky, J.; Prangé, T.; Pascard, C. J. Chem. Soc., Chem. Commun. 1982, 135-137.

. P Cremin, P J Guiry, J.-L Wolfender, K Hostettmann, D M X Donnelly, J. Chem. Soc., Perkin Trans. 1. Cremin, P.; Guiry, P.J.; Wolfender, J.-L.; Hostettmann, K.; Donnelly, D.M.X. J. Chem. Soc., Perkin Trans. 1 2000, 2325-2329.

. D M X Donnelly, J Polonsky, T Prangé, G Snatzke, U Wagner, J. Chem. Soc., Chem. Commun. Donnelly, D.M.X.; Polonsky, J.; Prangé, T.; Snatzke, G.; Wagner, U. J. Chem. Soc., Chem. Commun. 1984, 222-223.

. D M X Donnelly, F Abe, D Coveney, N Fukuda, J O&apos;reilly, J Polonsky, T Prangé, J. Nat. Prod. 48Donnelly, D.M.X.; Abe, F.; Coveney, D.; Fukuda, N.; O'Reilly, J.; Polonsky, J.; Prangé, T. J. Nat. Prod. 1985, 48, 10-16.

. D M X Donnelly, D J Coveney, N Fukuda, J J Polonsky, Nat, 49Donnelly, D.M.X.; Coveney, D.J.; Fukuda, N.; Polonsky, J. J. Nat. Prod. 1986, 49, 111-116.

. J.-S Yang, P.-Z Cong, Huaxue Xuebao. 46Yang, J.-S.; Cong, P.-Z. Huaxue Xuebao 1988, 46, 1093-1100.

. J S Yang, Y W Chen, X Z Feng, D Q Yu, C H He, Q T Zheng, J Yang, X T Liang, Planta Med. 55Yang, J.S.; Chen, Y.W.; Feng, X.Z.; Yu, D.Q.; He, C.H.; Zheng, Q.T.; Yang, J.; Liang, X.T. Planta Med 1989, 55, 564-565.

. C.-C Chen, Y.-H Kuo, J.-J Cheng, P.-J Sung, C.-L Ni, C.-C Chen, C.-C Shen, Molecules. 20Chen, C.-C.; Kuo, Y.-H.; Cheng, J.-J.; Sung, P.-J.; Ni, C.-L.; Chen, C.-C.; Shen, C.-C. Molecules 2015, 20, 9994-10003.

. M Misiek, J Williams, K Schmich, W Hüttel, I Merfort, C E Salomon, C C Aldrich, D Hoffmeister, J. Nat. Prod. 72Misiek, M.; Williams, J.; Schmich, K.; Hüttel, W.; Merfort, I.; Salomon, C.E.; Aldrich, C.C.; Hoffmeister, D. J. Nat. Prod. 2009, 72, 1888- 1891.

. M Bohnert, H.-W Nützmann, V Schroeckh, F Horn, H.-M Dahse, A A Brakhage, D Hoffmeister, Phytochemistry. 105Bohnert, M.; Nützmann, H.-W.; Schroeckh, V.; Horn, F.; Dahse, H.-M.; Brakhage, A.A.; Hoffmeister, D. Phytochemistry 2014, 105, 101- 108.

. M Misiek, D Hoffmeister, Mycol, 11ProgressMisiek, M.; Hoffmeister, D. Mycol. Progress 2012, 11, 7-15.

. M Bohnert, S Miethbauer, H.-M Dahse, J Ziemen, M Nett, D Hoffmeister, Bioorg. Med. Chem. Lett. Bohnert, M.; Miethbauer, S.; Dahse, H.-M.; Ziemen, J.; Nett, M.; Hoffmeister, D. Bioorg. Med. Chem. Lett. 2011, 21, 2003-2006.

. S L Midland, R R Izac, R M Wing, A I Zaki, D E Munnecke, J J Sims, Tet. Lett. 23Midland, S.L.; Izac, R.R.; Wing, R.M.; Zaki, A.I.; Munnecke, D.E.; Sims, J.J. Tet. Lett. 1982, 23, 2515-2518.

. Z Li, Y Wang, B Jiang, W Li, L Zheng, X Yang, Y Bao, L Sun, Y Huang, Y Li, J. Ethnopharmacol. 184Li, Z.; Wang, Y.; Jiang, B.; Li, W.; Zheng, L.; Yang, X.; Bao, Y.; Sun, L.; Huang, Y.; Li, Y. J. Ethnopharmacol. 2016, 184, 119-127.

. A Arnone, R Cardillo, G Nasini, Phytochemistry. 25Arnone, A.; Cardillo, R.; Nasini, G. Phytochemistry 1986, 25, 471-474.

. X Yin, T Feng, J.-K Liu, Nat. Prod. Bioprospect. 2Yin, X.; Feng, T.; Liu, J.-K. Nat. Prod. Bioprospect. 2012, 2, 245-248.

. A Arnone, R Cardillo, V Di Modugno, G Nasini, Gazz. Chim. Ital. 118Arnone, A.; Cardillo, R.; Di Modugno, V.; Nasini, G. Gazz. Chim. Ital. 1988, 118, 517-521.

. A Arnone, R Cardillo, G Nasini, Gazz. Chim. Ital. 118Arnone, A.; Cardillo, R.; Nasini, G. Gazz. Chim. Ital. 1988, 118, 523-527.

. I Momose, R Sekizawa, N Hosokawa, H Iinuma, S Maisui, H Nakamura, H Naganawa, M Hamada, T Takeuchi, J. Antibiot. 53Momose, I.; Sekizawa, R.; Hosokawa, N.; Iinuma, H.; Maisui, S.; Nakamura, H.; Naganawa, H.; Hamada, M.; Takeuchi, T. J. Antibiot. 2000, 53, 137-143.

Protoilludane norsesquiterpenoid esters and uses thereof. C.-C Chen, J.-J Cheng, C.-C Shen, Chen, C.-C.; Cheng, J.-J.; Shen, C.-C. Protoilludane norsesquiterpenoid esters and uses thereof. 2011, US 20110262561.

. D M X Donnelly, R M Hutchinson, D Coveney, M Yonemitsu, Phytochemistry. 29Donnelly, D.M.X.; Hutchinson, R.M.; Coveney, D.; Yonemitsu, M. Phytochemistry 1990, 29, 2569-2572.

. D M X Donnelly, T Konishi, O Dunne, P Cremin, Phytochemistry. 44Donnelly, D.M.X.; Konishi, T.; Dunne, O.; Cremin, P. Phytochemistry 1997, 44, 1473-1478.

. D M X Donnelly, D J Coveney, J Polonsky, Tet. Lett. 26Donnelly, D.M.X.; Coveney, D.J.; Polonsky, J. Tet. Lett. 1985, 26, 5343-5344.

. A Arnone, R Cardillo, G Nasini, S V Meille, J. Chem. Soc., Perkin Trans. 1. Arnone, A.; Cardillo, R.; Nasini, G.; Meille, S.V. J. Chem. Soc., Perkin Trans. 1 1988, 503-510.

. D M X Donnelly, P F Quigley, D J Coveney, J Polonsky, Phytochemistry. 26Donnelly, D.M.X.; Quigley, P.F.; Coveney, D.J.; Polonsky, J. Phytochemistry 1987, 26, 3075-3077.

. J S Yang, Y W Chen, X Z Feng, D Q Yu, X T Liang, Planta Med. 50Yang, J.S.; Chen, Y. W.; Feng, X. Z.; Yu, D. Q.; Liang, X. T. Planta Med. 1984, 50, 288-290.

. J Sonnenbichler, J.-J Guillaumin, H Peipp, D Schwarz, Eur. J. For. Path. 27Sonnenbichler, J.; Guillaumin, J.-J.; Peipp, H.; Schwarz, D. Eur. J. For. Path. 1997, 27, 241-249.

. J S Yang, Y L Su, Y L Wang, X Z Feng, D Q Yu, P Z Cong, M Tamai, T Obuchi, H Kondoh, X T Liang, Planta Med. 55Yang, J.S.; Su, Y.L.; Wang, Y.L.; Feng, X.Z.; Yu, D.Q.; Cong, P.Z.; Tamai, M.; Obuchi, T.; Kondoh, H.; Liang, X.T. Planta Med. 1989, 55, 479-481.

. J S Yang, Y L Su, Y L Wang, X Z Feng, D Q Yu, X T Liang, Yao Xue Xue, Bao, 25Yang, J.S.; Su, Y.L.; Wang, Y.L.; Feng, X.Z.; Yu, D.Q.; Liang, X.T. Yao Xue Xue Bao 1990, 25, 24-28.

. J S Yang, Y L Su, Y L Wang, X Z Feng, D Q Yu, X T Liang, C H He, Q T Zheng, J J Yang, J Yang, Yao Xue Xue, Bao, 25Yang, J.S.; Su, Y.L.; Wang, Y.L.; Feng, X.Z.; Yu, D.Q.; Liang, X.T.; He, C.H.; Zheng, Q.T.; Yang, J.J.; Yang, J. Yao Xue Xue Bao 1990, 25, 353-356.

. J S Yang, Y L Su, Y L Wang, X Z Feng, D Q Yu, X T Liang, Yao Xue Xue, Bao, 26Yang, J.S.; Su, Y.L.; Wang, Y.L.; Feng, X.Z.; Yu, D.Q.; Liang, X.T. Yao Xue Xue Bao 1991, 26, 117-122.

. J S Yang, Y L Su, Y L Wang, X Z Feng, D Q Yu, X T Liang, Planta Med. 57Yang, J.S.; Su, Y.L.; Wang, Y.L.; Feng, X.Z.; Yu, D.Q.; Liang, X.T. Planta Med. 1991, 57, 478-480.

Antibiotic armillaric acid and its manufacture with Armillaria mellea. J S Yang, S Watube, 1034956Yang, J.S.; Watube, S. Antibiotic armillaric acid and its manufacture with Armillaria mellea. 1989, CN 1034956.

. T Obuchi, H Kondoh, N Watanabe, M Tamai, S Omura, J S Yang, X T Liang, Planta Med. 56Obuchi, T.; Kondoh, H.; Watanabe, N.; Tamai, M.; Omura, S.; Yang, J.S.; Liang, X.T. Planta Med. 1990, 56, 198-201.

. D M X Donnelly, R M Hutchinson, Phytochemistry. 29Donnelly, D.M.X.; Hutchinson, R.M. Phytochemistry 1990, 29, 179-182.

. P Cremin, D M X Donnelly, J.-L Wolfender, K Hostettmann, J. Chromatogr. A. 710Cremin, P.; Donnelly, D.M.X.; Wolfender, J.-L.; Hostettmann, K. J. Chromatogr. A 1995, 710, 273-285.

. H Kobori, A Sekiya, T Suzuki, J.-H Choi, H Hirai, H Kawagishi, J. Nat. Prod. 78Kobori, H.; Sekiya, A.; Suzuki, T.; Choi, J.-H.; Hirai, H.; Kawagishi, H. J. Nat. Prod. 2015, 78, 163-167.

. J R Anderson, C E Briant, R L Edwards, R P Mabelis, J P Poyser, H Spencer, A J S Whalley, J. Chem. Soc. Chem. Commun. 7Anderson, J.R.; Briant, C.E.; Edwards, R.L.; Mabelis, R.P.; Poyser, J.P.; Spencer, H.; Whalley, A.J.S. J. Chem. Soc. Chem. Commun. 1984, 7, 405-406.

. T Sugimura, L A Paquette, J. Am. Chem. Soc. 109Sugimura, T.; Paquette, L.A. J. Am. Chem. Soc. 1987, 109, 3017-3024.

. J P Poyser, R L Edwards, J R Anderson, M B Hursthouse, N P C Walker, G M Sheldrick, A J S Whalley, J. Antibiot. 39Poyser, J.P.; Edwards, R.L.; Anderson, J.R.; Hursthouse, M.B.; Walker, N.P.C.; Sheldrick, G.M.; Whalley, A.J.S. J. Antibiot. 1986, 39, 167- 169.

. S T Deyrup, D C Swenson, J B Gloer, D T Wicklow, J. Nat. Prod. 69Deyrup, S.T.; Swenson, D.C.; Gloer, J.B.; Wicklow, D.T. J. Nat. Prod. 2006, 69, 608-611.

. Y Li, Q Wang, X Liu, Y Che, Biomed. Res. Int. 7871459Li, Y.; Wang, Q.; Liu, X.; Che, Y. Biomed. Res. Int. 2017, 7871459.

. Z Wu, D Liu, P Proksch, P Guo, W Lin, Mar. Drugs. 12Wu, Z.; Liu, D.; Proksch, P.; Guo, P.; Lin, W. Mar. Drugs 2014, 12, 3904-3916.

. I H Hwang, D T Wicklow, J B Gloer, Phytochem. Lett. 16Hwang, I.H.; Wicklow, D.T.; Gloer, J.B. Phytochem. Lett. 2016, 16, 257-262.

. S Xie, Y Wu, Y Qiao, Y Guo, J Wang, Z Hu, Q Zhang, X Li, J Huang, Q Zhou, Z Luo, J Liu, H Zhu, Y Xue, Y Zhang, J. Nat. Prod. 81Xie, S.; Wu, Y.; Qiao, Y.; Guo, Y.; Wang, J.; Hu, Z.; Zhang, Q.; Li, X.; Huang, J.; Zhou, Q.; Luo, Z.; Liu, J.; Zhu, H.; Xue, Y.; Zhang, Y. J. Nat. Prod. 2018, 81, 1311-1320.

. M F R Brasco, A M Seldes, J A Palermo, Org. Lett. 3Brasco, M.F.R.; Seldes, A.M.; Palermo, J.A. Org. Lett. 2001, 3, 1415-1417.

. Y Mogi, K Inanaga, H Tokuyama, M Ihara, Y Yamaoka, K Yamada, K Takasu, Org. Lett. 21Mogi, Y.; Inanaga, K.; Tokuyama, H.; Ihara, M.; Yamaoka, Y.; Yamada, K.; Takasu, K. Org. Lett. 2019, 21, 3954-3958.

. U F Castillo, Y Sakagami, M Alonso-Amelot, M Ojika, Tetrahedron. 55Castillo, U.F.; Sakagami, Y.; Alonso-Amelot, M.; Ojika, M. Tetrahedron 1999, 55, 12295-12300.

. C M Ma, N Nakamura, A Nawawi, M Hattori, S Q Cai, Chinese, Chem. Lett. 15Ma, C.M.; Nakamura, N.; Nawawi, A.; Hattori, M.; Cai, S.Q. Chinese Chem. Lett. 2004, 15, 65-67.

. J Wang, L.-X Zhang, Y Zhao, W.-X Chen, Q Yang, Y.-X Wang, Medicinal Plant. 251Wang, J.; Zhang, L.-X.; Zhao, Y.; Chen, W.-X.; Yang, Q.; Wang, Y.-X. Medicinal Plant 2011, 2, 40-43, 51.

Protoilludane sesquiterpenoid compound, preparation method and medical applications thereof. J Wu, 105418544Wu, J. Protoilludane sesquiterpenoid compound, preparation method and medical applications thereof. 2016, CN 105418544.